Crystal Structure of the Extracellular Domain of a Human FcγRIII

Slides:



Advertisements
Similar presentations
Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine  Snezana Djordjevic,
Advertisements

Volume 10, Issue 7, Pages (July 2002)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 9, Issue 2, Pages (February 2002)
A Fence-like Coat for the Nuclear Pore Membrane
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Volume 8, Issue 3, Pages (September 2001)
Tsan Xiao, Par Towb, Steven A. Wasserman, Stephen R. Sprang  Cell 
Crystal Structure of M. tuberculosis ABC Phosphate Transport Receptor
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Hierarchical Binding of Cofactors to the AAA ATPase p97
Crystal Structure of Maltose Phosphorylase from Lactobacillus brevis
by Alexey Dementiev, Abel Silva, Calvin Yee, Zhe Li, Michael T
Volume 14, Issue 9, Pages (September 2006)
Identification of Phe187 as a Crucial Dimerization Determinant Facilitates Crystallization of a Monomeric Retroviral Integrase Core Domain  Meytal Galilee,
Modular Recognition of RNA by a Human Pumilio-Homology Domain
Chaperone-Assisted Crystallography with DARPins
Tom Huxford, De-Bin Huang, Shiva Malek, Gourisankar Ghosh  Cell 
Structure of the Universal Stress Protein of Haemophilus influenzae
Mark Ultsch, Nathalie A Lokker, Paul J Godowski, Abraham M de Vos 
Volume 10, Issue 12, Pages (December 2002)
Volume 23, Issue 7, Pages (July 2015)
Structure of the Angiopoietin-2 Receptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition  William A. Barton, Dorothea Tzvetkova,
Volume 13, Issue 5, Pages (November 2000)
Volume 90, Issue 4, Pages (August 1997)
Einav Gross, David B Kastner, Chris A Kaiser, Deborah Fass  Cell 
Crystal Structure of the MHC Class I Homolog MIC-A, a γδ T Cell Ligand
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Crystal Structure of the Human High-Affinity IgE Receptor
Volume 31, Issue 2, Pages (July 2008)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 4, Issue 5, Pages (November 1999)
Volume 23, Issue 6, Pages (December 2005)
Crystal Structure of Recombinant Human Interleukin-22
Structure of the Cathelicidin Motif of Protegrin-3 Precursor
Andrew H. Huber, W.James Nelson, William I. Weis  Cell 
Crystal Structure of β-Arrestin at 1.9 Å
Volume 18, Issue 2, Pages (April 2005)
Volume 18, Issue 6, Pages (June 2010)
Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains  Beth A. Wurzburg, Scott C. Garman, Theodore.
Volume 9, Issue 8, Pages (August 2001)
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 9, Issue 12, Pages (December 2001)
Volume 14, Issue 2, Pages (April 2004)
Volume 91, Issue 5, Pages (November 1997)
Volume 16, Issue 8, Pages (August 2008)
Antonina Roll-Mecak, Chune Cao, Thomas E. Dever, Stephen K. Burley 
Volume 8, Issue 5, Pages (November 2001)
Volume 101, Issue 4, Pages (May 2000)
Volume 91, Issue 7, Pages (December 1997)
ICAT Inhibits β-Catenin Binding to Tcf/Lef-Family Transcription Factors and the General Coactivator p300 Using Independent Structural Modules  Danette.
A Putative Mechanism for Downregulation of the Catalytic Activity of the EGF Receptor via Direct Contact between Its Kinase and C-Terminal Domains  Meytal.
Structural Basis for FGF Receptor Dimerization and Activation
Volume 15, Issue 6, Pages (December 2001)
Structural Basis of Rab Effector Specificity
Tertiary Structure of Destrin and Structural Similarity between Two Actin-Regulating Protein Families  H Hatanaka, K Ogura, K Moriyama, S Ichikawa, I.
Solution Structure of a TBP–TAFII230 Complex
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Volume 91, Issue 5, Pages (November 1997)
Volume 5, Issue 10, Pages (October 1997)
Structure of Type IIβ Phosphatidylinositol Phosphate Kinase
Volume 20, Issue 1, Pages (January 2012)
Volume 13, Issue 5, Pages (May 2005)
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Structure of CD94 Reveals a Novel C-Type Lectin Fold
Structure of an IκBα/NF-κB Complex
Structure and Dimerization of a Soluble Form of B7-1
Crystal Structure of β-Arrestin at 1.9 Å
Structure of GABARAP in Two Conformations
Volume 95, Issue 2, Pages (October 1998)
Presentation transcript:

Crystal Structure of the Extracellular Domain of a Human FcγRIII Yihong Zhang, Christian C. Boesen, Sergei Radaev, Andrew G. Brooks, Wolf-Herman Fridman, Catherine Sautes-Fridman, Peter D. Sun  Immunity  Volume 13, Issue 3, Pages 387-395 (September 2000) DOI: 10.1016/S1074-7613(00)00038-8

Figure 1 Sequence Alignment of Human Fc Receptors Amino acids identical to the sequence of FcγRIIa are not shown. The secondary structure elements of FcγRIII are shown above the sequence with the D1 domain in black and the D2 domain in gray. Residues involved in the interdomain hinge packing are boxed in red. Residues in the putative Fc binding region are shown in magenta. Immunity 2000 13, 387-395DOI: (10.1016/S1074-7613(00)00038-8)

Figure 2 Structure of FcγRIII (A) The N-terminal D1 and the C-terminal D2 domains are colored in blue and green, respectively. The putative ligand binding loops of FcγRIII are colored in red. The strands for the D1 domain are A (5–12), A′ (17–20), B (22–33), C (39–45), C′ (47–52), E (55–61), F (66–73), and G (77–85) and the strands for the D2 domain are A (91–95), A′ (98–101), B (104–113), C (120–125), C′ (130–134), E (136–143), F (149–157), and G (163–172). Residues 146–149 form a short α helix. (B) Orientation of the D1 and D2 domains in KIR. The D2 domain of KIR is in a similar orientation to that of FcγRIII. (C) The interdomain hinge region. The D1–D2 domain of FcγRIII and their respective interdomain packing residues are shown in dark blue and green. The BC loop of the D2 domain is colored in orange. The dashed line indicates the salt bridge between Asp-23 and His-111. The superposition of the D1 domain on the D2 domain is shown in light blue and its BC loop in purple. (D) Superposition of the molecule A and B of FcγRIII in the asymmetric unit. A bound phosphate ion is found in molecule B but not in A. All ribbon figures are prepared using the program MOLSCRIPT and Raster3D (Kraulis 1991; Merritt and Bacon 1997). Immunity 2000 13, 387-395DOI: (10.1016/S1074-7613(00)00038-8)

Figure 3 The Structure of Fc Binding Region (A) The putative Fc binding region. The D1 and D2 domains of FcγRIII are shown in dark blue and green, respectively. Residues in the putative ligand binding region of FcγRIII are shown in ball-and-stick model. The D2 domain of FcεRI superimposed onto the D2 domain of FcγRIII is shown in light blue. (B) The Grasp representation of the electrostatic potential distribution at the putative interface of FcγRIII and the CH2 domain of IgG. Positive potentials are colored in blue, and negative potentials are in red. The putative interface regions are highlighted. The coordinates for Fc are taken from the structure of IgG2a, Protein Data Bank entry 1IGT. Immunity 2000 13, 387-395DOI: (10.1016/S1074-7613(00)00038-8)

Figure 4 Analysis of the FcγRIII and Fc Complex by Size-Exclusion Chromatography under Both Nonequilibrium and Equilibrium Conditions The apparent molecular weights of FcγRIII, Fc, and their complex are 25, 51, and 63 kDa, respectively. The predicted molecular masses for FcγRIII and Fc are 21.0 and 50.4 kDa, respectively. (A) Nonequilibrium gel filtration. The injection sample contains 10 μM FcγRIII or 10 μM Fc for the FcγRIII and Fc-only runs. The complexes were prepared with 10 μM Fc and various amounts of the receptor to give rise to the 1:1, 2:1, and 3:1 receptor:Fc molar ratio. (B) Equilibrium gel filtrations were carried out using a buffer containing 50 mM NaCl, 50 mM Tris (pH 8.0), and 10 μM FcγRIII. Samples contain 10 μM Fc with various amounts of FcγRIII as indicated in each curve. The elution volumes of FcγRIII and the FcγRIII:Fc complex are marked. Immunity 2000 13, 387-395DOI: (10.1016/S1074-7613(00)00038-8)

Figure 5 Fc Receptor Dimerization and Aggregation Model (A) Crystal lattice packing of molecule A (in red) and B (in green). (B) AA, BB, and AB parallel dimers. The dimers are formed through translational symmetry. The view is 90° from that of panel (A). D1 and D2 domains are colored in light blue and green. The interface residues are shown as ball-and-sticks in dark blue and green for the D1 and D2 domains, respectively. The predicted glycosylation sites are shown in magenta. The putative Fc binding loops are colored red. AB parallel dimer is formed between the two molecules in each asymmetric unit. (C) A hypothetical model of receptor aggregation based on the observed parallel AB dimer (in green) in crystal lattice. The antibody coordinates, colored in magenta and blue, are from Protein Data Bank entry 1IGT. Immunity 2000 13, 387-395DOI: (10.1016/S1074-7613(00)00038-8)